Protagonist Therapeutics, Inc.PTGXNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-15.04%
↓ 118% below average
Average (39q)
81.35%
Historical baseline
Range
High:3550.01%
Low:-802.76%
Volatility
5350.7%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -15.04% |
| Q2 2025 | -80.42% |
| Q1 2025 | -83.40% |
| Q4 2024 | 3550.01% |
| Q3 2024 | 12.19% |
| Q2 2024 | -98.37% |
| Q1 2024 | 324.92% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | -100.00% |
| Q2 2022 | -99.94% |
| Q1 2022 | 219.17% |
| Q4 2021 | -24.19% |
| Q3 2021 | 354.13% |
| Q2 2021 | -63.40% |
| Q1 2021 | 9.54% |
| Q4 2020 | -56.92% |
| Q3 2020 | 110.94% |
| Q2 2020 | 70.47% |
| Q1 2020 | 34.13% |
| Q4 2019 | -34.34% |
| Q3 2019 | 137.77% |
| Q2 2019 | -802.76% |
| Q1 2019 | -33.70% |
| Q4 2018 | -61.53% |
| Q3 2018 | -47.60% |
| Q2 2018 | 8.28% |
| Q1 2018 | -4.44% |
| Q4 2017 | 28.48% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |